Brewing Enzymes Market Analysis by Mordor Intelligence
Market Overview
The global brewing enzyme market reached USD 555.37 million in 2025 and is projected to expand to USD 802.51 million by 2030, registering a compound annual growth rate (CAGR) of 7.64%. This growth trajectory reflects the industry's accelerating shift toward precision fermentation technologies and sustainable brewing practices, with enzymes becoming indispensable for optimizing yield while reducing environmental footprint. The market's expansion is particularly driven by the craft brewing revolution and the rising demand for specialty beers, including gluten-free and low-alcohol variants that require sophisticated enzymatic solutions. The market is mainly driven by the increase in demand for beer and alcoholic beverages among consumers, which has resulted in an increased number of independent breweries, microbreweries, and brewpubs on a global level. However, regulations in the brewing industry by regulatory bodies such as the FDA, USDA, and EU are the major challenge that is restraining the market growth.
Key Report Takeaways
- By enzyme type, amylase held 37.74% of the brewing enzyme market share in 2024, while beta-glucanase is projected to grow at 8.05% CAGR from 2025-2030.
- By source, microbial enzymes commanded 73.58% share of the brewing enzyme market in 2024 and are forecast to expand at 8.74% CAGR through 2030.
- By form, liquid products led with 63.88% share of the brewing enzyme market in 2024, whereas dry formulations are set to climb at 9.05% CAGR over the same period.
- By application, beer production accounted for 86.32% share of the brewing enzyme market size in 2024, yet wine applications are expected to advance at 9.00% CAGR to 2030.
- By geography, Europe captured 33.47% revenue share in 2024; Asia-Pacific is the fastest-growing region at a 9.04% CAGR to 2030.
Global Brewing Enzymes Market Trends and Insights
Drivers Impact Analysis
Driver | (~) % Impact on CAGR Forecast | Geographic Relevance | Impact Timeline |
---|---|---|---|
Rising Demand for Craft and Artisanal Beer Worldwide | +1.8% | Global, with a concentration in North America & Europe | Medium term (2-4 years) |
Increasing Adoption of Enzymes in High Gravity Brewing | +1.5% | Global, particularly the Asia-Pacific emerging markets | Short term (≤ 2 years) |
Consumer Popularity of Gluten-Free and Low-Calorie Beers | +1.2% | North America & Europe, expanding to APAC | Medium term (2-4 years) |
Expanding Microbrewery and Home Brewing Culture | +1.0% | Global, with the strongest growth in Asia-Pacific | Long term (≥ 4 years) |
Surge in Demand for Lager and Light Beers in Emerging Markets | +0.9% | Asia-Pacific, Latin America, Middle East & Africa | Medium term (2-4 years) |
Flavor Innovation Through Controlled Enzymatic Conversion | +0.8% | Global, led by premium market segments | Long term (≥ 4 years) |
Source: Mordor Intelligence
Rising Demand for Craft and Artisanal Beer Worldwide
Craft brewing requires different enzymes compared to industrial brewing, creating opportunities for specialized enzyme suppliers to charge premium prices. Small-batch production needs precise fermentation control, leading to increased use of targeted enzyme solutions that maintain consistent quality despite varying ingredients. These solutions help craft brewers overcome challenges related to raw material inconsistencies and seasonal variations in ingredient quality. The USDA's National Institute of Food and Agriculture[1]USDA National Institute of Food and Agriculture, “Research Programs,” usda.gov has supported research on sustainable hop breeding and yeast contamination prevention, acknowledging craft brewing's economic importance. This research focuses on developing resilient hop varieties and improving quality control measures in craft brewing operations. Craft brewers use enzymes to develop distinct flavor profiles while optimizing production efficiency, as precision fermentation reduces greenhouse gas emissions compared to conventional methods. The adoption of enzymatic solutions allows brewers to achieve specific taste characteristics, improve yield, and maintain batch-to-batch consistency. This enables enzyme suppliers to increase profits through combined product sales and technical consulting services, particularly by offering customized enzyme formulations and process optimization guidance.
Increasing Adoption of Enzymes in High Gravity Brewing
High gravity brewing allows breweries to optimize facility usage by producing concentrated worts that are later diluted, which changes the enzyme requirements for starch conversion and protein modification. This brewing method involves creating a more concentrated beer during the brewing process and then diluting it to the desired alcohol content before packaging. The process reduces equipment, labor, and energy costs while increasing production capacity without requiring additional fermentation tanks or storage space. DSM-Firmenich's Maxadjunct ß L enzyme targets high-gravity brewing applications, enabling brewers to use local adjuncts while reducing energy consumption. The enzyme technology helps break down complex carbohydrates more efficiently during the brewing process, improving overall yield and consistency. This enhanced efficiency results in shorter brewing cycles and reduced water consumption per unit of beer produced. This technology is valuable in emerging markets where raw material costs vary significantly, as enzymes allow brewers to replace malted barley with alternative carbohydrate sources such as corn, rice, or other locally available grains. The flexibility in raw material selection helps breweries maintain production costs while ensuring consistent product quality despite market fluctuations in ingredient prices. Additionally, the use of local adjuncts supports regional agricultural economies and reduces transportation-related costs and environmental impact.
Consumer Popularity of Gluten-Free and Low-Calorie Beers
Enzymatic gluten reduction technology enables traditional breweries to produce gluten-free beer without investing in separate production facilities. This advancement significantly reduces capital expenditure while maintaining product quality. DSM-Firmenich's Brewers Clarex enzyme, currently used in 20% of beers globally, provides effective protein stabilization and gluten reduction capabilities. The enzyme's widespread adoption demonstrates its reliability and effectiveness in commercial brewing operations. The production of low-calorie beer requires precise enzyme control to maintain flavor complexity while achieving the target alcohol content. This technical requirement creates substantial demand for specialized enzyme solutions, as brewers seek to optimize their production processes. The growing consumer preference for healthier beer options has further accelerated the development of enzyme-based brewing solutions. Enzyme manufacturers continue to invest in research and development to meet these specific brewing requirements while ensuring consistent product quality.
Expanding Microbrewery and Home Brewing Culture
Small order volumes and limited technical expertise create procurement challenges for microbreweries, presenting opportunities for enzyme suppliers who provide educational support and flexible packaging. The growing home brewing segment has increased retail demand for brewing enzymes beyond traditional commercial applications. The expanding consumer market has prompted suppliers to develop specialized enzyme formulations tailored for small-scale brewing operations. These developments have created new distribution channels and product categories specifically targeting hobbyist brewers. Precision Fermentation's sustainability guidelines highlight how enzymes support water conservation and waste reduction in craft brewing operations. The decentralized nature of craft brewing enables regional enzyme suppliers to compete with large corporations by offering local service and technical assistance. This localized approach allows suppliers to better understand and respond to specific regional brewing requirements and challenges. Regional suppliers can also provide more immediate technical support and maintain closer relationships with local craft breweries.
Restraint Impact Analysis
Restraint | (~) % Impact on CAGR Forecast | Geographic Relevance | Impact Timeline |
---|---|---|---|
Regulatory Differences Across Countries | -1.2% | Global, particularly affecting cross-border trade | Medium term (2-4 years) |
Flavor Inconsistencies Caused by Overuse or Misuse of Enzymes | -0.8% | Global, with higher impact in emerging markets | Short term (≤ 2 years) |
Potential Allergen Concern in Genetically Engineered Enzymes | -0.6% | North America & Europe, with spillover to APAC | Long term (≥ 4 years) |
Environmental Sensitivity of Enzymes Reducing Shelf Life | -0.4% | Tropical regions, emerging markets with limited cold storage | Medium term (2-4 years) |
Source: Mordor Intelligence
Regulatory Differences Across Countries
The regulatory landscape for enzymes varies significantly between regions. The European Union [3]European Food Safety Authority, “Food Enzymes Regulation EC No 1332/2008,” efsa.europa.eurequires extensive safety documentation for pre-market approval under Regulation EC No 1332/2008, while the United States follows the FDA's GRAS (Generally Recognized as Safe) notification process. The USDA's National Bioengineered Food Disclosure Standard requires labeling of bioengineered foods[2]U.S. Food and Drug Administration, “GRAS Notice 1190 for AldB-Producing Yeast,” fda.gov, which may influence consumer acceptance in GMO-sensitive markets. These regulatory requirements create substantial barriers for companies seeking to enter multiple markets simultaneously. Regulatory harmonization remains challenging due to fundamental differences in safety assessment approaches - the US evaluates product characteristics, while the EU focuses on production processes. These regulatory differences require enzyme manufacturers to maintain distinct product portfolios and documentation systems. The need for separate compliance processes increases operational complexity and resource requirements for companies. As a result, manufacturers face higher compliance costs and longer market entry periods when expanding their geographical presence.
Flavor Inconsistencies Caused by Overuse or Misuse of Enzymes
The lack of technical expertise in emerging markets often results in incorrect enzyme application, leading to off-flavors that affect brand reputation and consumer trust. Optimizing enzyme activity requires precise control of temperature, pH, and timing parameters - knowledge that smaller breweries without technical staff often lack. The FDA's GRAS Notice 1190 for Saccharomyces cerevisiae strain OYR-481 illustrates these technical requirements, as this engineered yeast produces AldB enzyme to prevent diacetyl formation and needs specific protocols for effective results. The complexity of enzyme applications demands careful attention to processing conditions and a thorough understanding of biochemical interactions. Excessive use of clarifying enzymes can remove essential proteins that maintain beer foam stability and mouthfeel, creating irreversible quality issues. This challenge particularly affects breweries in developing markets where technical knowledge may be limited. Enzyme suppliers' educational and technical support services play a crucial role in market development, helping differentiate premium providers from commodity suppliers in price-sensitive markets. The success of enzyme applications largely depends on proper training, ongoing technical support, and clear communication of best practices to end-users.
Segment Analysis
By Type: Amylase Dominance Faces Beta Glucanase Challenge
Amylase enzymes hold a 37.74% market share in 2024, due to their essential function in starch conversion during the mashing process. Beta glucanase represents the fastest-growing segment with an 8.05% CAGR through 2030. The growth in beta-glucanase adoption reflects brewers' emphasis on improving filtration efficiency and beer clarity, as these enzymes break down beta-glucans that increase viscosity and impede filtration. For example, Biocatalysts Ltd's DELTABREW® liquid beta-glucanase targets viscosity reduction and enhances beer filtration. Protease enzymes play important roles in protein modification and foam stability, while AlphaLase provides additional amylolytic activity for specific brewing needs.
The brewing enzyme market is moving toward specialized applications as the industry becomes more sophisticated. Brewers now seek targeted enzyme solutions instead of general enzyme blends. Additional enzyme types, including lipases and cellulases, serve specific functions such as flavor development and adjunct processing, enabling specialized suppliers to implement premium pricing strategies. This transition to precise enzyme applications supports sustainability objectives by reducing raw material waste and energy consumption in brewing operations.

Note: Segment shares of all individual segments available upon report purchase
By Source: Microbial Precision Drives Market Leadership
Microbial enzymes hold 73.58% market share in 2024 and are projected to grow at 8.74% CAGR through 2030. This dominance stems from the biotechnology industry's shift toward fermentation-based production instead of traditional plant extraction methods. The precision fermentation process ensures consistent enzyme quality and allows property customization through metabolic engineering, meeting the brewing industry's requirements for reliable performance across operating conditions. Plant-based enzymes remain vulnerable to agricultural variations and seasonal availability, making microbial enzymes the preferred choice for large-scale brewing operations.
The use of genetically engineered microorganisms enables the production of enzymes with improved thermostability and pH tolerance, addressing specific brewing challenges including high-temperature mashing and acidic fermentation conditions. Microbial enzyme production reduces land use and water consumption compared to plant-based methods, supporting brewing industry sustainability goals. The production costs decrease with increased volume, making microbial enzymes economically advantageous for large brewing operations.
By Form: Liquid Convenience Versus Dry Stability
Liquid enzymes hold a dominant 63.88% market share in 2024, as brewers value their handling convenience and immediate solubility. Dry enzymes are projected to grow at a higher rate of 9.05% CAGR through 2030, driven by brewers seeking cost-effective, shelf-stable options. This growth pattern indicates a market transition toward dry formulations that eliminate cold-chain requirements and lower transportation costs, particularly in emerging markets. DSM-Firmenich offers both variants in their enzyme portfolio, with liquid products providing immediate activity and dry formulations offering extended shelf life in markets with limited refrigeration infrastructure. The temperature sensitivity of liquid enzymes presents storage challenges in tropical regions, increasing demand for stable dry formulations that maintain effectiveness in challenging conditions.
Recent developments in enzyme stabilization allow dry formulations to deliver performance comparable to liquid enzymes while offering improved logistics benefits. Advanced microencapsulation and spray-drying methods maintain enzyme activity during production and storage, resolving previous concerns about dry enzyme performance. Industry consolidation in brewing creates a need for standardized enzyme products suitable for global distribution without cold-chain requirements, supporting increased dry enzyme usage. As brewing margins decrease due to rising raw material costs, dry enzymes become more attractive due to their reduced logistics and storage expenses compared to liquid variants.

Note: Segment shares of all individual segments available upon report purchase
By Application: Beer Dominance Enables Wine Cross-Pollination
Beer applications account for 86.32% of the market share in 2024, demonstrating the brewing industry's extensive scale and established enzyme usage. Wine applications are growing at a 9.00% CAGR through 2030, as winemakers implement enzyme technologies proven in the brewing sector. This adoption pattern enables enzyme suppliers to apply their brewing expertise to wine production, particularly in clarification and flavor enhancement processes. The increasing premiumization in the wine industry drives the demand for enzyme solutions that improve product quality and consistency. Winemakers are investing in biotechnology solutions to differentiate their products in the market. IFF's Health & Biosciences segment exemplifies this trend by offering enzyme solutions for both brewing and wine applications.
Wine production faces similar challenges to brewing, including protein stabilization, filtration efficiency, and flavor development. These shared challenges create operational synergies that reduce development costs for enzyme suppliers. While the wine industry operates at a smaller scale, its higher margins support premium enzyme pricing, balancing the price pressures in the brewing sector. The regulatory approval process for wine enzymes typically aligns with brewing enzyme standards, allowing suppliers to use existing safety data across both applications. Technological advancements in protein engineering and fermentation optimization benefit the entire alcoholic beverage sector, creating value for both wine and beer production.
Geography Analysis
Europe maintains a 33.47% market share in 2024, built on established brewing traditions and regulatory frameworks that support enzyme adoption. The European Food Safety Authority (EFSA) implements clear enzyme approval processes while upholding safety standards that build consumer trust. Major brewers, including Diageo, Carlsberg, AB Inbev, and Heineken, incorporate sustainability initiatives that increase enzyme usage to minimize energy and water consumption.
The Asia-Pacific brewing enzymes market projects a 9.04% CAGR through 2030, supported by economic growth and rising consumer demand for premium alcoholic beverages. China's brewing industry modernization creates opportunities for enzyme suppliers as brewers adopt international quality standards. India's growing middle class requires enzyme solutions to address raw material variations and maintain beer quality. Japan's brewing sector provides opportunities for enzyme applications in premium products. The region's diverse brewing methods, including rice-based and tropical fruit fermentation, require specialized enzyme solutions. Regional producers Angel Yeast Co. Ltd. and Jiangsu Boli Bioproducts compete with global suppliers through localized products and technical support.
North America's brewing market focuses on innovation and craft brewing development, backed by the USDA's National Institute of Food and Agriculture's research in sustainable hop breeding and yeast contamination prevention. The craft brewing segment requires specific enzyme solutions for unique flavor profiles and efficient small-batch production. Latin America, the Middle East, and Africa markets show growth potential as brewing infrastructure develops and regulations evolve. Market expansion in these regions relies on economic advancement, infrastructure improvement, and increased consumer awareness of premium beer quality, creating opportunities for enzyme suppliers focused on market development and technical support.

Competitive Landscape
The brewing enzyme market shows moderate concentration with a score of 7 out of 10. Market leaders compete through technical expertise and application-specific solutions, moving beyond price-based competition. Major players in the market include Amano Enzyme Inc., Associated British Foods plc, DuPont de Nemours, Inc., Novozymes A/S, and DSM-Firmenich. DSM-Firmenich has positioned itself in premium segments by focusing on sustainability, specifically targeting carbon footprint reduction and energy efficiency.
Emerging markets present opportunities for regional suppliers who understand local brewing traditions and raw materials, requiring customized enzyme solutions. Competition intensifies through technological advancement, with companies investing in precision fermentation and metabolic engineering to develop enhanced enzymes. The FDA's GRAS Notice 1190 for engineered yeast strains provides a regulatory framework for biotechnology innovation.
New market entrants use biotechnology advances to target specialized segments, such as gluten-free brewing and alcohol-free beer production, where specialized enzymes command higher prices. Success in this market depends on strong research and development capabilities and regulatory expertise, given the substantial investment required for safety testing and multi-jurisdictional market approvals.
Brewing Enzymes Industry Leaders
-
Amano Enzyme Inc.
-
Associated British Foods plc
-
DuPont de Nemours, Inc.
-
DSM-Firmenich
-
Novozymes A/S
- *Disclaimer: Major Players sorted in no particular order

Recent Industry Developments
- January 2024: Lallemand Bio-Ingredients acquired Swiss biotechnology firm Evolva for USD 23 million to produce complex enzyme molecules from yeast products. This acquisition strengthens Lallemand's position in the biotechnology sector and expands its capabilities in enzyme production. The integration of Evolva's expertise enables Lallemand to enhance its product portfolio and meet growing market demand for specialized enzyme solutions.
- January 2024: Novozymes A/S and Chr. Hansen Holding A/S completed their merger to form Novonesis, creating a global leader in biotechnology solutions with enhanced capabilities in brewing enzyme development and expanded geographic reach. The merger combines Novozymes' enzyme expertise with Chr. Hansen's fermentation technologies, positioning the new entity to capture synergies in brewing applications and accelerate innovation in sustainable biotechnology solutions.
- December 2023: Kerry Group plc completed its EUR 150 million acquisition of the lactase enzyme business from Chr. Hansen and Novozymes, following European Commission approval. The acquisition enhances Kerry's biotechnology solutions portfolio and expands its presence in the growing lactose-free products market, demonstrating strategic focus on specialty enzyme applications.
Global Brewing Enzymes Market Report Scope
Brewing enzymes are used for uniform mashing, secure stability, optimizing the usage of raw materials, and improving filtration. These enzymes help increase saccharification, and starch liquefaction, which helps increase the production of fermentable sugars. The brewing enzymes market is segmented based on source into the plant and microbial sources; by type into amylase, alphalase, protease, and others; and by form into liquid and dry. By geography., the market segmentation includes North America, Europe, Asia-Pacific, South America, and the Middle East and Africa. The report offers market size and forecast in value terms in USD million for all the above segments.
By Type | Amylase | ||
Alphalase | |||
Beta Glucanase | |||
Protease | |||
Other Types | |||
By Source | Microbial | ||
Plant | |||
By Form | Dry | ||
Liquid | |||
By Application | Beer | ||
Wine | |||
By Geography | United States | Canada | |
Mexico | |||
Rest of North America | |||
Europe | United Kingdom | ||
Germany | |||
Spain | |||
France | |||
Italy | |||
Russia | |||
Rest of Europe | |||
Asia-Pacific | China | ||
India | |||
Japan | |||
Australia | |||
Rest of Asia Pacific | |||
South America | Brazil | ||
Argentina | |||
Rest of South America | |||
Middle East and Africa | Saudi Arabia | ||
South Africa | |||
Rest of Middle East and Africa |
Amylase |
Alphalase |
Beta Glucanase |
Protease |
Other Types |
Microbial |
Plant |
Dry |
Liquid |
Beer |
Wine |
United States | Canada |
Mexico | |
Rest of North America | |
Europe | United Kingdom |
Germany | |
Spain | |
France | |
Italy | |
Russia | |
Rest of Europe | |
Asia-Pacific | China |
India | |
Japan | |
Australia | |
Rest of Asia Pacific | |
South America | Brazil |
Argentina | |
Rest of South America | |
Middle East and Africa | Saudi Arabia |
South Africa | |
Rest of Middle East and Africa |
Key Questions Answered in the Report
What is the projected size of the brewing enzyme market by 2030?
The brewing enzyme market is forecast to reach USD 802.51 million by 2030, growing at a 7.64% CAGR.
Which enzyme type dominates the brewing enzyme market?
Amylase leads with a 37.74% share in 2024, reflecting its central role in starch conversion during mashing.
Which region is growing fastest in the brewing enzyme market?
Asia-Pacific is expanding at a 9.04% CAGR through 2030 due to rising premium beer consumption and brewery modernization.
Why are microbial enzymes preferred over plant-based alternatives?
Microbial fermentation offers consistent quality, scalable supply and lower environmental footprint, giving microbial enzymes a 73.58% market share.
Page last updated on: July 6, 2025